Live Breaking News & Updates on Dermira Inc|Page 2

Stay updated with breaking news from Dermira inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Journey Medical (DERM) & Maruho Ink Deal for Qbrexza Asia Rights

Journey Medical (DERM) enters into a second licensing agreement with Maruho to develop and commercialize Qbrexza to treat hyperhidrosis in certain Asian countries. The stock surges 18.4%. ....

Eli Lilly , Zacks Investment Research , Journey Medical Corporation , Dermira Inc , Journey Medical Corporation Price , Image Source , Zacks Investment , Journey Medical , Medical Corporation Price , Medical Corporation , Zacks Rank , Dynavax Technologies , Better Therapeutics , Corcept Therapeutics , Strong Buy , Zacks Consensus Estimate , Better Therapeutic , Ourney Medical Corporation Derm , Licensing Agreement , Aruho Co , Medical Corporation , Upfront Payment , Journey Medical , Axillary Hyperhidrosis , Onsensus Estimate ,

ReCode Therapeutics Appoints Erica Jefferson as Senior Vice President of Corporate Affairs

– Former FDA Associate Commissioner of External Affairs brings nearly 20 years of communications, patient advocacy and public affairs experience across government, public and private sectors –MENLO PARK, Calif. (BUSINESS WIRE) ReCode Therapeutics, a clinical-stage genetic medicines company using superior delivery. ....

United States , Tara Cooper , Erica Jefferson , Shehnaaz Suliman , College Park , Dermira Inc , Drug Administration , Grace Communication Group , Pharmacyclics Inc , American Pharmacists Association , Alector Inc , Johns Hopkins University , University Of Maryland , External Affairs , Recode Therapeutics , American Pharmacists , Code Therapeutics , Fierce Biotech ,

Journey Medical Corporation (NASDAQ:DERM) Q1 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the Journey Medical s First Quarter 2023 Financial Results and Corporate Update Conference Call. ....

Claude Maraoui , Joseph Benesch , Matt Blazei , Journey Medical Corporation , Dermira Inc , Call Transcript May , Medical Corporation , Journey Medical , First Quarter , Corporate Update Conference , Investor Relations , Chief Executive Officer , Interim Chief Financial , East West ,

Global Atopic Dermatitis Drugs Market to 2030: Increasing

Dublin, April 11, 2023 (GLOBE NEWSWIRE) The "Atopic Dermatitis Drugs Market Size, Share & Trends Analysis Report by Drug Class (Biologics, PDE4. ....

United States , Eli Lilly , Forte Biosciences Inc , Public Companies , Regulatory Political , Route Of Administration Market Share Analysis , Pfizer Inc , Key Company Market Share Analysis , Administration Topical , Route Of Administration , Japanese Dermatological Association , Regeneron Pharmaceuticals Inc , Otsuka Pharmaceutical Co Ltd , Dermira Inc , Company Categorization , Otsuka Holdings Co Ltd , Abbvie Inc , Porter Five Forces Analysis , Valeo Pharma Inc , Otsuka Pharmaceutical Co , Incyte Corporation , Demira Inc , Company Profiles , Dermatitis Drugs Market Size , Trends Analysis Report , Drug Class ,

Journey Medical Corporation (NASDAQ:DERM) Q4 2022 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. ....

New Jersey , United States , Srini Sidgiddi , Matt Blazei , Srinivas Sidgiddi , Brandon Folkes , Joseph Benesch , Ramsey Alloush , Claude Maraoui , Scott Henry , Communication Services Stocks To Invest , Biggest New Jersey Companies , Journey Medical Corporation , Cantor Fitzgerald , Dermira Inc , Call Transcript March , Journey Medical , Fourth Quarter , Fiscal Year , Corporate Update Conference , Investor Relations , Chief Executive Officer , Interim Chief Financial Officer , General Counsel , Vice President , Maruho Limited ,